Sequencing technology status of BRCA1/ 2 testing in Latin American Countries

NPJ Genom Med. 2020 Jun 2:5:22. doi: 10.1038/s41525-020-0126-3. eCollection 2020.

¹ INBIOMED, Facultad de Medicina UBA/CONICET and Genotipificacion y Cancer Hereditario, Dto. de Analisis Clínicos, CEMIC, Buenos Aires, Argentina.
² Molecular Oncology Research Center, Barretos Cancer Hospital and Barretos School of Health Science, Dr Paulo Prata, FACISB, Barretos, Brazil.
³ Unidad de Oncogenética, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
⁴ CIPE, International Research Center; A.C.Camargo Cancer Center, Sao Paulo, Brazil.
⁵ Tecnologico de Monterrey. Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico.
⁶ INVEGEM/ROZAS BOTRÁN ONG, Guatemala, Guatemala.
⁷ Hospital de Niños, Universidad de Costa Rica, San José, Costa Rica.
⁸ GIOD Group, Universidad Cooperativa de Colombia, Pasto, and Human Molecular Genetics Lab, Universidad del Valle, Cali, Colombia.
⁹ ICCBM, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
¹⁰ Department of Cancer Biology and Genetics, Division of Human Genetics, Department of Internal Medicine, Comprehensive Cancer Center, the Ohio State University, Columbus, OH United States.

No abstract available

Keywords: Cancer; Next-generation sequencing.